Featured Commentaries
ISPOR’s 2022 Health Economics and Outcomes Research Awards: ICER Honoree, Dr. Melanie Whittington
ISPOR announced the 2022 HEOR Awards. ICER’s Director of Health Economics, Dr. Melanie Whittington, received the Bernie O’Brien New Investigator Award, which recognizes those who have shown evidence of exceptional promise based on their emerging body of technical and scholarly work in the field of health economics.
09/13/2022Celebrating ICER’s Impact Over the Last 15+ Years
ICER was founded in 2006, and we celebrated our 15th anniversary in 2021. To mark that occasion, we put together a document celebrating ICER’s demonstrable impact. We also want to acknowledge the work of our staff and all the external stakeholders – patient advocates, clinicians, manufacturers, payers, health policy experts, and more — that have enabled […]
07/25/2022Morningstar: How Drug Pricing Can Increase ESG Risks for Pharmaceutical Stocks
While investors making bets on R&D need the potential of big financial returns, we believe that value-based drug pricing sends the right signal to the drug industry and venture capital firms about the kind of innovation we all want funded.
06/28/2022